Opportunity Assessment


Our client needed R&D executives to meet corporate goals and restructuring efforts.


Our team represented their Chief Medical Officer and Vice President of Development to advance a current phase 2 clinical trial in Traumatic Brain Injury.


C2C provided ongoing support to the organization as part of their reorganization to focus activities towards licensing and acquiring stem cell technologies from research institutions positioning themselves as a bridge to translate basic stem cell research into commercial products.